Zydus Cadila gets USFDA nod for cancer drug with 180-days exclusivity

Zydus Cadila gets USFDA nod for cancer drug with 180-days exclusivity

The company has received approval from the US Food and Drug Administration (USFDA) for the Nelarabine injection 250 MG/50ML, a generic version of Arranon injection.
Check the source here –Source, Financial Express.
Change Language